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Autologous chondrocyte implantation is the current gold standard cell therapy for carti-
lage lesions. However, in some instances, the heavily compromised health of the patient 
can either impair or limit the recovery of the autologous chondrocytes and a satisfactory 
outcome of the implant. Allogeneic human articular chondrocytes (hAC) could be a good 
alternative, but the possible immunological incompatibility between recipient and hAC 
donor should be considered. Herein, we report that allogeneic hAC inhibited T lympho-
cyte response to antigen-dependent and -independent proliferative stimuli. This effect 
was maximal when T cells and hAC were in contact and it was not relieved by the addition 
of exogenous lymphocyte growth factor interleukin (IL)-2. More important, hAC impaired 
the differentiation of peripheral blood monocytes induced with granulocyte monocyte 
colony-stimulating factor and IL-4 (Mo) to professional antigen-presenting cells, such as 
dendritic cells (DC). Indeed, a marked inhibition of the onset of the CD1a expression and 
an ineffective downregulation of CD14 antigens was observed in Mo–hAC co-cultures. 
Furthermore, compared to immature or mature DC, Mo from Mo–hAC co-cultures did not 
trigger an efficacious allo-response. The prostaglandin (PG) E2 present in the Mo–hAC 
co-culture conditioned media is a putative candidate of the hAC-mediated inhibition of 
Mo maturation. Altogether, these findings indicate that allogeneic hAC inhibit, rather than 
trigger, immune response and strongly suggest that an efficient chondrocyte implantation 
could be possible also in an allogeneic setting.
Keywords: allogenic cells, T lymphocyte, immune response, antigen-presenting cells, dendritic cells, chondrocyte 
implantation
inTrODUcTiOn
Articular cartilage, the joints load-bearing tissue, has limited repair and regeneration capacity (1). 
Chondrocytes, the only cell type present in articular cartilage comprising only 2–5% of the total 
cartilage volume, are responsible for regulating the integrity and homeostasis of the tissue by their 
ability to synthesize the structural components of the extracellular matrix (ECM) (2). Cartilage 
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lesions caused by trauma or diseases have been recognized as 
a cause of significant morbidity, affecting a significant part of 
the worldwide population. As consequence, after uncontrolled 
inflammation courses, the unique therapeutic option to restore 
or replace the dysfunctional tissue is the transplantation of 
somatic chondrocytes or stem cells with or without the use of 
guided biomaterials (3–5). Successful outcome of cell-based 
cartilage engineering depends on cells ability to form homeo-
static and functional tissue, with the appropriate formation of 
cartilaginous matrix to achieve the load-bearing capabilities of 
the natural tissue. Autologous chondrocyte implantation (ACI) 
is the current gold standard cell therapy for cartilage lesions 
(6). ACI, like others autologous therapies, requires articular 
tissue to be removed from healthy area of the knee cartilage, 
which rises donor site morbidity associated with reduction 
of function and increasing of pain over time (7). With the 
use of autologous cells in ACI, the immunological barriers to 
transplantation are fairly low. On the other hand, an allogeneic 
chondrocyte therapy would cancel the donor site morbidity 
and reduce time and costs while retaining the regenerative 
component of the cellular therapy. In this case, the successful 
transplantation of allogeneic cells requires the overcome of 
several immunological barriers involved in allo-recognition 
phenomena during an inflammatory response process. Also, it 
has been reported that although human articular chondrocytes 
(hAC) can express HLA-DR and ICAM1, they do not trigger 
an efficient allogeneic immune response (8). Furthermore, hAC 
can substitute monocytes in triggering T cell proliferation to 
mitogenic polyclonal stimuli, such as phytohemoagglutinin 
A (PHA) (8). Altogether these findings would support the idea 
that hAC can actively interact with lymphocytes and influence 
their proliferative response. Thus, it is relevant to define whether 
human chondrocytes may affect T cell response specifically 
triggered through CD3 T cell receptor complex and why 
T  lymphocytes cannot recognize allo-chondrocytes. It is well 
established that T cells can respond to foreign peptide antigen 
associated with major hystocompatibility molecules expressed 
on professional antigen-presenting cells (APC) as dendritic 
cells (DC) (9). In this work, we have analyzed the ability of 
allogeneic hAC to regulate T cell-mediated immune response 
and the effect exerted on the differentiation of peripheral blood 
(PB) Mo to DC. Indeed, the use of allogeneic chondrocytes 
in cartilage defects and osteoarthritis (OA) disease, character-
ized by articular cartilage loss and synovial inflammation (10), 
should be further improved with the knowledge of the kind of 
interaction between hAC and immune cells.
MaTerials anD MeThODs
Monoclonal antibodies and reagents
Monoclonal antibodies (mAbs) specific for CD3 (UCHT-1, IgG1 a 
gift of PCL Beverley, London and JT3A, IgG2a), anti-HLA-I (3A3, 
IgM, a gift of Dr E. Ciccone, University of Genoa), anti-HLA-DR 
(D1.12, IgG2a, a gift of Dr. R. Accolla, University of Insubria, 
Varese), anti-CD33 (ATCC, IgG1, HB-10306), anti-CD34 (ATCC, 
HB-12346, IgG1), anti-CD44 (T61/7, IgG1), anti-CD45 (ATCC, 
9.4, IgG2a), anti-CD73 (ATCC, IgG2b, HB-10744), anti-CD105 
(ATCC HB-10743, IgG1), CD31 (89D3, IgG2a), anti-CD25 (9.3, 
IgG1) anti-CD16 (KD1, IgG2a), anti-CD14 (63D3, IgG1, a gift 
of Dr D. Vercelli, HSR San Raffaele, Milan) were used as culture 
supernatant. Anti-CD1a-FITC, anti-CD80-Vio, anti-CD83-APC, 
anti-CD86-PE, and anti-CD14PE-Cy7 were from ExBioPraha, 
Goat anti-mouse anti-isotype-specific second reagent conjugated 
with PE or Alexafluor 647 and beads coated with anti-CD3 and 
anti-CD28 mAbs were from Life Technologies (Milan Italy) 
and used according to instructions of manufacture. TGFβ-1, 
granulocyte monocyte colony-stimulating factor (GM-CSF), 
and IL-4 were from Peprotech Inc. (London, UK). Recombinant 
human interleukin (IL)-2 was from Miltenyi Biotech. Adenosine, 
kynurenine, prostaglandin E2 (PGE2), bacterial lyposaccharide 
(LPS), PHA, and staphyloenterotoxin B (SEB) fetal bovine serum 
(FBS) for lymphocytes, hyaluronidase, collagenase I, collagenase 
II, trypsin, dexamethasone, ascorbic acid, and phosphate-
buffered saline (PBS) were from Sigma Chemical. All chemicals 
and bacterial-derived substances were used in a biosafety level 2 
laboratories according to the safety procedures of IRCCS AOU 
San Martino IST. Coon’s modified HAM’s F-12 medium was 
from Biochrom AG (Berlin Germany), glutamine, FBS for hAC 
and Ficoll Hypaque for separation of lymphocytes were from 
Euroclone (Milan, Italy). RPMI1640 medium for lymphocyte 
cultures was from GIBCO and (CFSE) (Life Tecnologies, Milan, 
Italy). ATPLite assay kit was from Perkin Elmer (Monza, Italy). 
The negative selection kits for isolation of T cells and CD4+ T cells 
or do-it-yourself kit for positive selection of CD14+ monocytes 
were purchased from Stemcell Tecnologies (Vancouver, Canada).
specimens of human articular 
chondrocytes and Peripheral Blood 
Mononuclear cells
Human articular chondrocytes were harvested from adult articu-
lar cartilage from the femoral condyles of 20 patients undergo-
ing partial knee replacement (age mean =  70  years, n =  20). 
Peripheral blood mononuclear cells (PBMC) were obtained from 
buffy coats (n =  35, age mean 45  years, range 18–50  years) of 
healthy donors and used within 1-day gathering. All biological 
samples were obtained in consensus with the guidelines and 
with the approval of the Institutional Ethics Committee and after 
signed institutional informed consent.
isolation and culture of hac
Human articular chondrocyte were obtained as described by 
Pereira et  al. (11). In brief, single articular chondrocytes were 
released by repeated digestions using an enzymatic solution 
composed by 1  mg/ml hyaluronidase, 400  U/ml collagenase I, 
1000 U/ml collagenase II, and 0.25% trypsin in PBS. Isolated cells 
were united and cultured in 2D adhesion using Coon’s modified 
Ham’s F-12 supplemented with 10% FCS, 2  mM glutamine, 
100  U/ml penicillin, and 100 μg/ml streptomycin. At ~90% of 
confluence, cells were detached and plated at different densities. 
During culture, cells were monitored using a bright field micro-
scope (Axiovert 40 CFL) equipped with a digital camera (Canon 
Power Shot G8).
TaBle 1 | Primers used to evaluate the gene expression of human articular chondrocytes by real-time quantitative Pcr.
gene Forward reverse
GAPDH 5′-ACAGTCAGCCGCATCTTCTT-3′ 5′-ACGACCCAAATCCGTTGACTC-3′
Collagen type I 5′-CATCTCCCCTTCGTTTTTGA-3 5′-CCAAATCCGATGTTTCTGCT-3′
Collagen type II 5′-GACAATCTGGCTCCCAAC-3′ 5′-ACAGTCTTGCCCCACTTAC-3
Aggrecan 5′-TGAGTCCtTCAAGCCTCCTGT-3′ 5′-TGGTCTGCAGCAGTTGATTC-3′
SOX-9 5′-TACGACTACACCGACCACCA-3′ 5′-TTAGGATCATCTCGGCCATC-3′
3
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chondrogenic Differentiation assay
Chondrogenic potential of hAC was investigated by the pellet cul-
ture (12). About 2.5 × 105 cells were pelleted in 15 ml conical tubes 
and cultured for 21  days in the chondrogenic medium; Coon’s 
F-12 modified Ham’s medium supplemented with human trans-
forming growth factor-β1 (10 ng/ml), dexamethasone (10−7 M) 
and ascorbic acid (50 mg/ml) according to Johnstone et al (13). 
Media were changed every 2  days. Tissue characteristics were 
evaluated by histology. Moreover, we test ectopic cartilage forma-
tion in athymic mice; 3D pellets were maintained for 2–3 days 
in vitro before subcutaneous implantation in CD-1 nu/nu mice 
(Charles River Italia). Animals were sacrificed, and implants were 
recovered after 4 weeks for the histological analysis of cartilage 
formation (14). All animals were maintained in accordance with 
standards of the Federation of Eu-Laboratory Animal Science 
Association, as required by the Italian Ministry of Health and 
with the approval of the Institutional Ethic Committee (Research 
project n.336).
histology and immunohistochemistry 
characterization
Pellets and recovered implants were fixed in 4% formaldehyde 
in PBS, dehydrated in ethanol, and paraffin embedded. Cross 
sections (5 μm) were cut, dewaxed, and stained with toluidine 
blue for detection of sulfated glycosaminoglycan. For immuno-
histochemical analysis, sections were dewaxed and treated with 
methanol:hydrogen peroxide (49:1) for 30 min and then treated 
with 1 mg/ml hyaluronidase in PBS (pH 6.0) for 30 min at 37°C and 
washed with PBS. Slices were then incubated with goat serum for 
1 h to reduce non-specific binding. The type II collagen antibody 
diluted 1:250 (CIICI anti-COLLII, DSHB, University of Iowa) was 
added and incubated for 1 h at room temperature. The procedure 
was performed using a Histomouse Kit (Zymed Laboratories). 
Detection was detected with the biotinylated secondary antibody 
and streptavidin–peroxidase. The oxidase activity was visualized 
by the AEC (3-amino-9-ethylcarbazole) chromogen substrate. 
Histology and immunohistochemistry slides were observed at 
different magnifications and images acquired with the Axiovert 
200M microscope (Carl Zeiss).
gene expression characterization
Total RNA was extracted from hAC using Trizol® reagent accord-
ing to the manufacture’s instructions (Invitrogen, CA, USA) and 
kept at −80°C for subsequent RNA extraction (14). Briefly, cells 
were incubated at 4°C for 10 min with chloroform (Sigma) and 
centrifuged at 13000 rpm for 15 min; 700 μl supernatant were col-
lected and an equivalent volume of isopropanol (Sigma/I-9516) 
was added. After RNA precipitation, samples were centrifuged at 
13000 rpm and 4°C for 15 min. The supernatant was removed and 
700 μl of 70% ethanol was added. Tubes were again centrifuged at 
13000 rpm at 4°C for 5 min, and the supernatant was removed. The 
pellets were left to air-dry at RT and at the end were resuspended in 
50 μl DNase/RNase-free distilled water (Gibco/10977-015). RNA 
content and integrity was assessed using a NanoDrop (NanoDrop 
Technologies, USA). Isolated RNA was transcribed into cDNA 
using the iScript cDNA synthesis kit (1708891). Gene expres-
sion levels were quantified by real-time quantitative RT-PCR 
(qPCR) using ABI Prism 7700 Sequence Detector (Applied 
Biosystems) according to the manufacturer’s instructions and 
using the primers reported in Table 1. Data were analyzed for 
the gene of interest and normalized for the housekeeping gene 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) using 
ΔCT expression ratio following MIQE guidelines.
isolation of PBMc, PBMc–hac  
co-cultures experiments, and 
evaluation of T lymphocyte Proliferation
Peripheral blood mononuclear cells were separated from blood 
samples of healthy donors as described (15). hAC the day before 
the co-culture experiment were detached from culture flask, 
washed and 105, 0.5 × 105 and 0.25 × 105 cells were seeded in 
96 flat-bottomed microwells plates in RPMI 1640 medium sup-
plemented with10% of FBS. The day after the culture medium 
was discarded and hAC were co-cultured with PBMC at different 
PBMC:hAC ratios (20:1, 10:1, 5:1) in RPMI 1640 supplemented 
with 10%FBS, glutamine, and antibiotics or in the presence of 
anti-CD3mAb (JT3A. IgG2a, 20 ng/ml), PHA (5 μg/ml), or SEB 
(10 ng/ml) in U-bottomed microplates in 200 μl and proliferation 
kinetics was evaluated at 3, 5, and 7 days of culture. Cell prolifera-
tion was assessed after labeling PBMC with CFSE according to 
manufacturer’s instructions. Proliferation was assessed by cyto-
fluorimetric evaluation of progressive loss of CFSE proportional 
to cell division, on gated T cells labeled with anti-CD3 mAb 
(UCHT-1, IgG1) followed by AlexaFluor 647-conjugated anti-
isotype specific goat anti-mouse antiserum (Life Technologies, 
Milan, Italy) (16). In preliminary experiments, this assay gave 
comparable results to assays based on uptake of radiolabeled thy-
midine or evaluation of ATP content by ATPlite assay kit (Perkin 
Elmer, Waltham, MA, USA). In some experiments, recombinant 
IL-2 (2 ng/ml, Miltenyi Biotech, Germany) was added on day 2 to 
determine at days 3,5, and 7 the responsiveness of lymphocytes 
to this cytokine and determine the kinetics of response to IL-2. 
To determine the role of hAC–PBMC contact in regulating 
lymphocyte cell proliferation, in some experiments, PBMC were 
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seeded on Millicell transwell® (TW) with 0.3 μm pores (Millipore 
Corporation, Billerica, MA, USA) put in 24-well plates with hAC 
seeded on the bottom to avoid hAC–PBMC contact. In some 
experiments, hAC and PBMC were co-cultured in 24-well plates 
and CFSE labeled PBMC put in TW in the same culture well. The 
ratio between PBMC and hAC was the same as when cultured in 
flat-bottomed microplates; indeed, the number of cells in cul-
ture was proportional to the plastic growth area. In this setting, 
soluble factors produced during the PBMC–hAC contact in the 
lower chamber can diffuse in the upper TW and their influence 
on response to proliferating signals can be detected. Isolation 
of CD4+ T cells was performed using Rosettesep negative isola-
tion kit for CD4+ T cells following manufacture’s instructions 
(Stemcell Technologies, Vancouver, BC, Canada). The purity of 
CD4+ T cell populations was always >95% (ranging from 95 to 
100%). CD4+ T cells were co-cultured with hAC at the CD4+: 
hAC ratio of 5:1 and proliferation to CD3–CD28 mAb-coated 
beads evaluated on days 3, 5, and 7. The same samples were also 
analyzed for the expression of CD25 (IL-2Rα) with anti-CD25 
mAb (clone 93, IgG1) followed by Alexa 647-conjugated goat 
anti-mouse on days 2, 4, and 6 to analyze the kinetics of expres-
sion. In some experiments, 2 ng/ml of IL-2 was added on day 2 
of the co-culture experiments.
isolation of Peripheral Blood Mo, 
generation In Vitro of Dendritic cells,  
and co-cultures with hac
CD14+ Mo were positively isolated from PBMC with Easy-sep 
“do-it-yourself kit” (Stemcell Technologies) using the anti-CD14 
mAb clone 63D3 IgG1 isotype (Biolegend, San Diego, CA, USA). 
The purity of CD14+ cells was more than 85% (range from 85 to 
95%). To generate immature (i) DC, CD14+ Mo were cultured 
with 20  ng/ml of GM-CSF and 20  ng/ml of IL-4 for 6  days as 
previously described (9, 17). Additional culture of immature DC 
(iDC) with LPS (1 μg/ml) induces their differentiation to mature 
(m) DC (9,  17). Generation of iDC was characterized by the 
downregulation of CD14 antigen and neo-expression of CD1a. 
Maturation of iDC to mature DC (mDC) was evidenced by the 
upregulation of accessory molecules as CD80, CD83, and CD86, 
co-culture experiments with hAC were performed in 24-well 
microplates (Euroclone) at different Mo:hAC ratios of 10:1, 20:1, 
40:1, 80:1, 160:1. The co-cultures experiments were performed 
in contact or seeding Mo in Millicell transwell (Millipore, TW) 
as indicated for co-cultures with PBMC. Conditioned media 
(CM) from the different conditions were collected, centrifuged at 
10,000 rpm for 10 min, and stored at −80C for further analysis.
Prostaglandin e2 (Pge2) Quantification 
by elisa
Determination of PGE2 content in conditioned media (CM) 
from culture of Mo and hAC with GM-CSF and IL-4 differentia-
tion cytokines was performed using a PGE2 specific ELISA kit 
(Cayman, Ann Arbor, MI 48108, USA). Content of PGE2 in CM 
of control cultures of Mo with GM-CSF and IL-4 as well as that 
from hAC was analyzed for comparison. The CM was harvested 
on day 4 of culture to allow production of soluble factors but 
avoiding their consuming as defined in preliminary experiments. 
Results are expressed as picogram/milliliter of PGE2.
cytofluorimetric assays
In indirect immunofluorescence assay cells were stained with the 
indicated mAbs followed by incubation with anti-isotype specific 
goat anti-mouse antiserum conjugated with the fluorochromes 
indicated. Samples were run on a CyAN ADP cytofluorimeter 
equipped with three lasers (Vio405, Argon 488, and He-Neon 
613), compensation between the different fluorochromes was 
performed by analyzing samples stained with single antibodies 
and by auto-compensation analysis. At least 105 events were 
analyzed in each instance and data are represented as Log fluo-
rescence intensity vs. number of cells (single immunostaining) 
or as Log fluorescence intensity vs. Log fluorescence intensity in 
double or multicolor (5-color immunostaining for Mo differen-
tiation) immunofluorescence. In some experiments, also physical 
parameters as forward scatter (FSC) and side scatter (SSC) were 
shown to indicate the cell populations analyzed.
Cell populations derived from co-cultures of Mo and hAC did 
not contain detectable number of the last ones. This notion was 
supported by the findings that the amount of large cells character-
ized by high FSC and SSC harvested from Mo cultured with hAC 
was negligible (see Figure S2C in Supplementary Material). In 
addition, the initial number of hAC put in culture with Mo was 
of about 5 × 104 at a 10:1 Mo:hAC ratio (that means 5 × 105 Mo) 
after 6 days of cultures only 10 × 104 of floating cells were put 
in culture with allo-T lymphocytes. Thus, as about 1–3% of cells 
did not express markers of Mo–DC, the putative amount of hAC 
could be about 1–3% of 10 × 104 cells (10–30 × 102 of total cells). 
The ratio in allo-test was 10:1 T vs. DC that is about 100–300 of 
total hAC. This amount is really too low to get T cell inhibition 
evident at 10:1 and 5:1 PBMC:hAC ratios. In addition, virtually all 
cells harvested from co-cultures with hAC were CD45+ (a marker 
absent on hAC), excluding the possibility that residual hAC were 
present during allo-response assay.
Mixed lymphocyte reaction Using iDc, 
mDc, and Mo cultured with hac, hac as 
stimulator in Mlr and as Third Party in 
Mlr assay
Mixed lymphocyte alloreaction (MLR) was performed with 
T cells isolated from PBMC by negative Rosettesep kit (Stemcell 
Tecnologies, Vancouver, BC, Canada) following manufacture’s 
instructions modified (15). The purity of T cell populations 
obtained was always more than 98% (range 98–100%). T cells 
were put in culture in 200 μl/well in flat-bottomed plates in the 
presence of allogeneic iDC, mDC, or Mo cultured with hAC for 
6  days as described in Section “Chondrogenic Differentiation 
Assay.” These APC were harvested from cultures and washed 
three times and seeded at 10:1 T:APC ratio (105 T cells vs. 104 
APC). The purity of these APC was always >99% as assessed 
by the expression of APC specific markers CD86 and CD45 
leukocyte common antigen (not shown). Proliferation was 
evaluated by ATPLite assay kit (Perkin Elmer) on day 6 of culture. 
Proliferation of only T cells (negative control), or T cell and Mo 
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(as a measure of MLR in the presence of unprofessional APC) or 
T cells in the presence of CD3–CD28-coated beads (as maximal 
level proliferation of T cells) was analyzed for comparison. In this 
case, proliferation was assessed as ATP content of cell cultures 
as the number of iDC, mDC, Mo, and Mo derived from co-
cultures with hAC were limited and this assay was adequate to 
perform several replicates of the same culture condition and so 
many different combinations. Indeed, ATPlite assay gave similar 
results (evaluated as degree of proliferation) of those obtained 
with CFSE labeling, in preliminary experiments. This allowed us 
to use ATPlite instead of CFSE labeling in some selected experi-
ments. In other experiments, hAC have been used as stimulator in 
co-cultures with allogeneic PBMC at the PBMC:hAC ratio of 10:1 
(105 PBMC vs. 104 hAC) in flat-bottomed 96-well microplates. In 
these experiments, hAC were seeded 2 days before the allogeneic 
PBMC. PBMC was labeled with CFSE and proliferation analyzed 
as decrement of CFSE content in CD3+ gated T cells. Some MLR 
assays were performed on hAC as third party at the responder 
PBMC:hAC ratio of 10:1 (105 PBMC vs. 104 hAC); in these experi-
ments, stimulator was represented by another irradiated PBMC. 
In this case, proliferation of responder T cells was evaluated as 
decrement of CFSE content of CFSE labeled responder PBMC.
statistical analysis
Statistical analysis of results was performed applying the two tails 
student t-test on at least n = 6 independent experiments using dif-
ferent donors of hAC and PBMC or APC. Data were considered 
statistically significant with a p < 0.05 and p-value is indicated 
with an asterisk (*).
resUlTs
cultured hac Maintain cartilage somatic 
Functional Properties In Vitro
Ex vivo isolation and culture of adult hAC gives raise to cells with 
restrict maintenance of their somatic assets. One of the main 
limitations of using these adult somatic cells in tissue regenera-
tion therapies is the limited capacity to preserve their phenotype 
and genotype memoir over time (18). Figure 1 illustrates how 
isolation of hAC was performed and the morphological features 
of hAC in vitro cultured (Figure 1A). Cytofluorimetric analysis 
(Figure  1B) indicated that hAC can express, although at low 
level, HLA class I and II antigens; indeed, the mean fluorescence 
intensity (MFI) of HLA-I expressed on leukocytes was 100 times 
higher than MFI that showed by hAC; furthermore, on PB Mo 
HLA-DR was about 500 times more expressed than on hAC 
(not shown). Most interestingly, the expression of both HLA 
antigens on hAC appeared to be bimodal. On the other hand, 
CD44, CD73, CD105, and CD90 markers were present on hAC 
but not CD309, CD31 (Figure 1B) CD45, CD14, CD34, CD33, 
CD80, and CD86 (not shown). It is of note that CD44, CD73, and 
CD105 showed a monomodal and quite homogeneous expres-
sion. The maintenance of the cartilage phenotype of the cultured 
hAC was further confirmed by the mRNA expression of typical 
markers of hAC, such as collagen type II, aggrecan, and sox-9 
transcription factor (Figure 1C). Furthermore, the cultured cells 
retained the ability to form cartilage both in a 3D differentiation 
system in vitro and when implanted in vivo (Figure 1D). Finally, 
hAC did show a clear reactivity with sox9 and collagen type II by 
indirect immunofluorescence and confocal microscope analysis 
(Figure 1E).
Altogether, these findings were consistent in all the primary 
cultures analyzed (n = 20), and hAC were used in functional assay 
independently from the age of the original specimen from which 
they were isolated. Indeed, hAC maintained their differentiation 
potential throughout the culture period of 2 months as previously 
described (14).
Peripheral Blood T lymphocyte 
Proliferation is regulated by cultured hac
To define whether hAC can regulate T lymphocyte proliferation 
to mitogenic stimuli, we labeled PBMC with CFSE, put them in 
culture with hAC in the presence of anti-CD3 mAbs, PHA, or 
SEB, and decrement of CFSE content in association with identifi-
cation of T lymphocytes by CD3 antigen expression was analyzed 
by flow cytometry. The use of these three different mitogenic 
stimuli was performed to clarify whether the effect of hAC was 
dependent on the kind of stimulus employed to trigger prolifera-
tion. Indeed, PHA can trigger T cells through the interaction with 
several activating receptors expressed on T cells while SEB can 
preferentially trigger T lymphocyte through the interaction with 
β-chain of T  cell antigen receptor (TCR) (19). Anti-CD3 mAb 
can mimic the triggering elicited through TCR as it is well estab-
lished that CD3 is the molecular complex associated with TCR, 
which delivers the signal inside the lymphocyte upon the specific 
antigen interaction with TCR (19–21). Furthermore, PHA can 
bind several sugar moieties expressed on molecules that can be 
also expressed on non-T non-B lymphocytes as Mo and natural 
killer cells. These cells can have a role in supporting T lympho-
cyte proliferation (19, 22). Thus, these three types of stimuli can 
mimic different physiological conditions upon which T cells can 
respond. Most importantly, all the stimuli used are effective when 
in the cell culture are present functional monocytes that can help 
T cell to proliferate giving to T cells the second accessory signal 
needed for an efficient immune response (9).
We found that hAC can markedly inhibit T lymphocyte prolif-
eration to any of the stimuli applied (Figures 2A,B; Figure S1 in 
Supplementary Material). It is to point out that the hAC-mediated 
inhibiting effect was dependent on the ratio between PBMC and 
hAC. Indeed, proliferation was abrogated when PBMC:hAC 
ratio was 5:1 while the inhibitory effect almost disappeared at 
the PBMC:hAC ratio of 20:1 (Figure 2A). More importantly, we 
noted that the observed inhibition at PBMC:hAC ratio of 5:1 was 
evident only when PBMC and hAC were able to interact each 
other. Indeed, hAC did not exert any inhibiting effect on T cell 
proliferation when PBMC and hAC were cultured in the same 
culture well but separated by an insert cell chamber (Figure 2B). 
This in vitro system allowed the diffusion of soluble factors but 
it did inhibit the PBMC–hAC contact. Furthermore, we found 
that soluble factors produced upon PBMC–hAC interaction can 
affect lymphocyte proliferation; indeed, PBMC seeded in insert 
cell chamber displayed less proliferation when in the same cul-
ture well in the lower chamber hAC and PBMC were in contact 
(Figures 2B,C to clarify the different experimental conditions). 
AB C
E
D
FigUre 1 | Phenotypic features of hac. (a) Schematic representation of surgical specimens of articular cartilage (on the left), enzymatic digestion and 2D cell 
expansion in culture (middle) and images of cultured hAC (on the right). 1, 2, 3, and 4 represent schematically the anatomic architecture of cartilage divided by 
zones: (1) superficial tangential; (2) middle; (3) deep, and (4) calcified cartilage zone. Histological explants characterization: (a) hematoxylin and eosin and (b) immune 
detection of collagen type II. (B) Phenotype of hAC assessed by cytofluorimetry with mAbs to the indicated surface molecules (HLA-class I, HLA-class II DR 
antigens, CD44, CD73, CD105, CD90, CD309, and CD31). Results are shown as log fluorescence intensity vs. number of cells. In each subpanel are shown the 
negative control (light gray histogram) and the expression of the indicated antigens (dark gray histogram). In each panel are indicated the % of positive cells and their 
mean fluorescence intensity (MFI) in arbitrary units (a.u.). (c) ΔCT ratio of mRNA expression in cultured hAC of either collagen type I or type II, or aggrecan or sox-9 
transcription factor and GAPDH housekeeping gene. (D) Histological staining of 3D pellet culture cross sections. (a,b) In vitro pellet formed by human articular 
chondrocytes. (a) toluidine blue staining, (b) immunohistochemical expression of collagen type II. (c,d) In vivo subcutaneous implantation of pellets. Pellets were 
formed by hAC, after 2 weeks in culture, these pellets were then implanted in nude mice. (c) toluidine blue staining, (d) alcian staining. Scale bar = 100 μm. 
(e) Expression of nuclear Sox9 (green) and extracellular collagen II (blue) on hAC assessed by confocal microscopy. The expression of HMGB1 (red) as a nuclear 
marker is shown to identify nucleus. The merge image is also shown. Bar = 10 μm. 400× magnification.
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Altogether, these findings suggest that hAC upon contact with 
PBMC can deliver an inhibiting signal to T cell proliferation; 
this signal is also mediated by soluble factors produced during 
hAC–PBMC interaction.
hac inhibit cD4+ T cell Proliferation 
Triggered through the engagement of cD3 
and cD28 surface receptors
Furthermore, to analyze whether hAC can affect proliferation 
of T cells by acting directly on this cell population or indirectly 
by inhibiting Mo dependent co-stimulation of T lymphocytes, 
we purified CD4+ T cells from PBMC and this lymphocyte 
subset have been assessed for mitogenic response to beads 
coated with anti-CD3 and anti-CD28 mAb. Indeed, to stimulate 
proliferation of highly purified CD4+ T cells is necessary to 
give two different activation signals: the first one is mediated 
through CD3 and the second one through CD28 accessory 
molecule; thus, CD4+ T cells can proliferate in the absence of 
accessory cells as Mo (19–21). Proliferation of CD4+ T cells was 
assessed at different time points to analyze proliferation kinetics 
(Figure 3A). We found that CD4+ T cells did not proliferate to 
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FigUre 2 | human articular condrocyte (hac) regulate T cell proliferation. (a) T cell proliferation of CD3+ T cells with the indicated stimuli at different 
PBMC:hAC ratio (20:1, 10:1, 5:1) or PBMC alone (medium). (B) T cell proliferation of PBMC on hAC at the PBMC:hAC ratio of 5:1 in contact or separated by a 
Millicell transwell chamber (TW, PBMC in TW) or by PBMC in TW separated by a co-cultures of PBMC and hAC (TW-contact). Results are the mean ± SD of eight 
different experiments. (c) Schematic representation of the different culture conditions: contact (a,B), TW (B), and TW-Contact (B). *p < 0.001 vs. PBMC.
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anti-CD3–CD28 mAb-coated beads when cultured with hAC 
(Figure 3A; Figure S2A in Supplementary Material). It is of note 
that CD4+  T cells in CD4-hAC co-cultures with anti-CD3–CD28 
mAb-coated beads did not show the typical morphology of 
large blast cells that, on the other hand, could be detected in 
the absence of hAC (Figure S2B in Supplementary Material). 
Furthermore, the addition of exogenous IL-2 to cell cultures 
did not relieve inhibition of CD4+ T cell proliferation exerted 
by hAC (Figure 3A). Altogether, these findings strongly suggest 
that hAC can directly inhibit T cell activation independently 
on accessory cells as Mo. The lack of recovery by the addi-
tion of IL-2 would indicate that the hAC-mediated inhibiting 
effect could affect also the IL-2R expression on CD4+ T cells. 
Indeed, it has been found a strong reduction of CD25 expres-
sion on lymphocytes when CD4+ T cells were co-cultured with 
hAC and triggered with anti-CD3–CD28 mAb-coated beads 
(Figures  3B,C).
effect of hac on Monocyte Differentiation 
to Dendritic cells
To deeply analyze the inhibiting effect of hAC on proliferation 
of T lymphocytes observed using PBMC, we further determined 
whether hAC could affect differentiation of PB Mo to profes-
sional APC as DC. Indeed, it is well established that APC as 
Mo and DC can play a key role in triggering lymphocytes upon 
mitogenic stimulation (19–21). Thus, the potent inhibiting effect 
exerted by hAC on T cell proliferation could be also determined 
by an impaired differentiation of Mo to DC. To this aim, highly 
purified Mo (Figure S3 in Supplementary Material) were iso-
lated from PB and cultured for 6 days with GM-CSF and IL-4 to 
induce their differentiation to the so-called iDC neo-expressing 
CD1a antigen and upregulating accessory co-stimulatory 
molecules as CD80, CD83, and CD86. Furthermore, by the 
addition of LPS and culture for additional 2 days, we analyzed 
also whether iDC were differentiated to mDC characterized by 
a stronger expression of CD80 and CD86 accessory molecules 
[17]. This set of experiments was performed in the presence of 
hAC at the Mo–hAC ratio of 10 to 1. iDC were harvested on day 
6 of culture and analyzed for the surface expression of CD1a, 
CD14, CD80, CD83, and CD86 (Figure  4 represents results 
of six independent experiments, Figure S4 in Supplementary 
Material shows dot plots of a representative experiment). Mo 
differentiates into iDC upon culture with GM-CSF and IL-4 as 
they neo-expressed CD1a and the degree of expression of CD14 
was strongly reduced. Accessory molecules as CD80, CD83, 
and CD86 were upregulated in iDC compared to isolated Mo 
(Figure 4, and in Figure S4 in Supplementary Material compare 
second row with the first row of dot plots). It is of note that 
in the presence of hAC–Mo did not differentiate to iDC as 
CD14 antigen was still expressed at very high levels and CD1a 
was very slightly upregulated (Figure  4, and in Figure S4 in 
Supplementary Material compare the third row with the second 
row of dot plots). Furthermore, the addition of LPS increased the 
level of expression of CD83 and CD86 on iDC leading to their 
maturation to mDC (Figure 4); this effect was strongly inhibited 
in co-cultures with hAC (Figure  4). hAC can affect both the 
percentage of Mo-derived DC cells expressing a given antigen 
and the level of its expression indicated as MFI (Figure  4). 
Although not shown, it should be noted that the inhibition of 
Mo differentiation to iDC or mDC exerted by hAC appeared 
to be very strong as it was still maximal at 1:160 hAC:Mo ratio. 
Altogether, these findings would indicate that hAC could inhibit 
Mo differentiation to iDC and mDC.
Mo-Derived cells co-cultured with hac 
Did not stimulate T cell allo-response
To further reinforce the notion that hAC can affect the gen-
eration of functional professional DC, we tested whether DC 
populations from Mo–hAC co-cultures were able to trigger 
lymphocyte proliferation to allo-antigen (Figure  5). Indeed, 
iDC and mDC can trigger a stronger response of T cells to 
allo-antigen than unprofessional APC as Mo (23). Thus, hAC 
blocking DC generation could impair alloantigen response. To 
this aim, Mo were cultured with GM-CSF and IL-4 for 6 days 
either without or with hAC and were further used as stimulator 
for purified T allo-lymphocytes. This kind of experiment was 
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FigUre 3 | effect of hac on cD4+ T cell proliferation and il-2r expression triggered through the engagement of cD3 and cD28 surface receptors. 
(a) CD4+ T cell proliferation to coated beads with anti-CD3 and anti-CD28 mAb at the time points indicated (3, 5, and 7 days). IL-2 (2 ng/ml) was added on day 2 of 
culture. Medium: proliferation of CD4+ T cells without mAb-coated beads. Results are the mean ± SD of six independent experiments. *p < 0.001 of CD4+ T 
cell-hAC co-cultures vs. CD4+ T cells alone. (B,c) CD4+ T cells stimulated with CD3–CD28 beads were analyzed for the expression of CD25 (IL-2Rα chain) on day 2 
(B,c) 4 and 6 (c) by indirect immunofluorescence using specific anti-CD25 mAb followed by isotype specific Alexafluor 647-conjugated goat anti-mouse and FACS 
analysis. Medium: expression of CD25 antigen in the absence of stimuli. (B) A representative experiments out of the six depicted in (c). Results in (c) are the 
mean ± SD of six experiments performed with different donors of CD4+ T cells and four donors of hAC. *p < 0.001.
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also performed with cells that were cultured for additional 
2  days with LPS, such as mDC. As shown in Figure  5, iDC 
and mDC can efficiently trigger T cell allo-response; indeed, 
the level of proliferation of allo-T cells was stronger than that 
induced by Mo (compare T cell proliferation with iDC, mDC, 
and Mo as first, third, and fifth group of Figure 5). Importantly, 
the mitogenic stimulus exerted by iDC or mDC to allo-T cells 
was comparable to that exerted by anti-CD3 and anti-CD28 
coated beads, used as a rate of maximal proliferation of T cells. 
This indicates that iDC and mDC were indeed professional 
APC. Moreover, it is of note that Mo-derived populations 
obtained from co-cultures with hAC did not trigger T cell 
allo-response. Indeed, proliferation of T cells was slightly higher 
than that of T cell alone (without any stimulus) and less strong 
than that triggered by Mo (compare second, fourth group of 
responses with the fifth of the Figure 5).
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relevance of soluble Factors as 
Mediators of hac-Dependent inhibition of 
Mo Differentiation: role of Pge2
To define the molecular mechanism underlines the inhibition of 
Mo differentiation to professional APC, we cultured PB Mo with 
GM-CSF and IL-4 in the presence of putative soluble inhibitors of 
Mo differentiations. To this aim, we employed adenosine, kynure-
nine, and prostaglandin E2. Indeed, it has been reported that each 
of this factor can have a role on Mo differentiation to DC (24); 
furthermore, kynurenine and PGE2 have been reported as relevant 
soluble mediators secreted in co-cultures with mesenchymal stro-
mal cells (MSC) and Mo able of blocking Mo differentiation to 
DC. We found that PGE2 can inhibit Mo differentiation to DC as 
it blocked CD1a upregulation and CD14 down regulation char-
acteristically observed in Mo cultured with GM-CSF and IL-4 
(Figure  6A). On the other hand, l-kynurenine (10–1–0.1 μM, 
Figure  6B) and adenosine (10–1–0.1 μM, Figure  6C) did not 
consistently affect differentiation to DC triggered with GM-CSF 
and IL-4. These findings prompt us to determine whether 
conditioned medium (CM) from Mo–hAC co-cultures was able 
to affect Mo differentiation and contained PGE2. As shown in 
Figure S5 in Supplementary Material, we found that CM from 
Mo–hAC cultures stimulated with GM-CSF and IL-4 can affect 
downregulation of CD14 and increase of expression of CD1a. 
More importantly, PGE2 was detectable in this CM (Figure 6D), 
suggesting that the effect on Mo differentiation exerted by CM 
could be dependent on the presence of this factor.
human ac Do not stimulate allo-
response and inhibit Mlr as a Third Party
We further analyzed whether hAC could function as stimula-
tor of allogenic PBMC. For this aim PBMC labeled with CFSE 
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FigUre 5 | Mo-derived cells harvested from co-cultures with hac do not trigger the allo-response of T cells. Cells derived from culture of peripheral 
blood Mo with GM-CSF + IL-4 (6 days, indicated as iDC) or GM-CSF + IL-4 + LPS (6 days of GM-CSF + IL-4 + 2 days of LPS, indicated as mDC) without or with 
hAC were harvested, extensively washed and put again in culture with allo-T cells purified from unrelated donors (T) at the T:antigen-presenting cell ratio of 10:1. The 
effect of unstimulated Mo [as the minimal triggering of proliferation of T cells and of CD3–CD28 mAb-coated beads (CD3-CD28 coated beads)] as the maximal T cell 
proliferation is shown for comparison. Results are expressed as counts of luminescence evaluating the ATP content in proliferating cell cultures and they are the 
mean ± SD of eight independent experiments using six different hAC preparations and eight healthy unrelated T cell donors. *p < 0.001.
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were added to hAC seeded at the PBMC:hAC ratio of 10:1 
and proliferation of CD3+ T cells was evaluated on day 7 of 
culture. As shown in Figure 7A, hAC did not trigger prolifera-
tion of T cells of three different allogeneic donors, indeed only 
about 10% of CD3+ T cells showed a decrease of CFSE content 
(Figure 7A, p < 0.001, comparing proliferation of leukocytes in 
co-cultures of hAC and leukocytes vs. MLR between leukocytes 
and analyzing all the data reported). On the other hand, T cells 
of each donor of PBMC were triggered by allo-antigens but not in 
presence of self cells. This behavior indicates that PBMC used in 
these experiments were able to respond to allo-antigens. Finally, 
we analyzed if allogeneic hAC could inhibit MLR when added as 
a third party. Thus, MLR was performed on allogeneic hAC at the 
responder T cells:hAC ratio of 10:1 and proliferation evaluated 
as decrease of CFSE content in responder T cells. We have found 
that three different preparations of allogeneic hAC inhibited by 
60–70% MLR proliferation (Figure  7B, p <  0.001, comparing 
proliferation in MLR with hAC as third part vs. proliferation of 
MLR and analyzing collectively the data). Altogether, these find-
ings strongly suggest that hAC act as veto cells in allo-response.
DiscUssiOn
Herein, we have shown that hAC can regulate immune response 
influencing directly the activation of T lymphocytes and indirectly 
impairing the differentiation of PB Mo induced by GM-CSF and 
IL-4 to professional APC as DC.
The inhibition of T cell proliferation was evident when hAC 
and lymphocyte were in close contact but not when these two 
cell populations were separated by a transwell system. However, 
soluble factors released in PBMC–hAC co-cultures passing 
through transwell can inhibit T cell proliferation, indicating that 
interaction between hAC and leukocytes is a requisite to deliver 
inhibiting signal. This inhibiting signal was evident on purified 
CD4+ T cells. This involved the impairment of the upregulation of 
IL-2R induced by appropriate stimuli interfering with IL-2/IL-2R 
signaling and consequent T lymphocyte proliferation. The inhibi-
tion of anti-CD3mAb-mediated proliferation would suggest that 
hAC can impair T cell antigen (TCR)-dependent activation (19) 
leading to a possible explanation of lack of allogenic stimulation of 
hAC observed in our experiments and reported by others (9). The 
impairment of proliferation with PHA or SEB support the notion 
that hAC can affect antigen independent T cell proliferation and 
triggering through bacterial products (19–21). Altogether, these 
observations reinforced the idea that regulatory activity of hAC 
on T cell response could have a role in articular joints injured by a 
trauma or inflamed during articular infections. hAC can strongly 
influence the maturation of Mo to iDC and mDC as well as their 
capacity to trigger as professional APC T cell proliferation. This 
finding support the idea that immune-regulation exerted by hAC 
can be exploited indirectly acting on professional APC matura-
tion and function as well. The inhibition on Mo differentiation 
was evident also when very low number of hACs was co-cultured 
with Mo during their maturation to iDC. Indeed, just one hAC 
vs. 100 or more Mo can fully impaired differentiation induced 
through GM-CSF and IL-4; on the other hand, inhibition of T cell 
proliferation was detectable at 10:1 T:hAC ratio. This suggests 
that hAC can regulate better Mo than T cells. This finding would 
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FigUre 6 | effect of Pge2, kynurenine, and adenosine on differentiation of Mo to iDc and presence of Pge2 in conditioned media of hac–Mo 
co-cultures. To determine the effect on the expression of exogeneous PGE2 (a) or kynurenine (B) or adenosine (c), Mo from PBMC were induced to differentiate to 
iDC with GM-CSF and IL-4 and incubated starting at the onset of culture with different doses (as indicated) of these three drugs. The expression of CD1a and CD14 
antigens were assessed with direct immunofluorescence using CD1a–FITC and CD14PE–Cy7 mAbs on day 6 of culture. Medium indicates the expression of CD1a 
and CD14 in cultures without the addition of any drug and it represents the typical differentiation of Mo to iDC. In (c), lined bar represents the expression of CD1a 
and CD14 in co-cultures with hAC showing the impairment in Mo differentiation to iDC. Results are shown as mean of fluorescence intensity of each marker and are 
the mean ± SD of three independent experiments for each drug. (D) The conditioned media (CM) from Mo co-cultured with hAC with GM-CSF and IL-4 was 
harvested on day 4 of culture and analyzed for the presence of PGE2 using a specific ELISA. The amount of PGE2 in CM from hAC or Mo is shown for comparison. 
Results are the mean ± SD of determination of three independent experiments. *p < 0.001.
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be relevant in the joint cartilage where Mo-derived macrophages 
have been reported to play a key role in rejection of hAC in a 
minipig model (25). Indeed, the co-localization of macrophages 
to hydrogel-implanted hAC suggested active graft rejection 
without evidence for an immune-privileged status of xenogeneic 
chondrocytes in this experimental system (25). In this context, it 
has also been reported that immune tolerance to allogeneic tissue 
engineered cartilage and subsequent implant survival is depend-
ent on the implant location and proximity to the synovium (26). 
Furthermore, it has been shown the safety and initial efficacy 
of a cell-based therapy using allogeneic juvenile chondrocytes 
delivered percutaneously for the treatment of lumbar spondylosis 
with mechanical low-back pain (27). Altogether these findings 
would suggest that the immune response to allogeneic hAC could 
be dependent on the microenvironment that hAC encounter and 
how these hAC are delivered. This notion is further supported by 
the observation that stress and tissue fluid microenvironments 
can greatly impact the differentiation and immunological proper-
ties of the engineered cartilage (28); furthermore, the use of cul-
tured chondrocytes in artificial scaffolds may create a temporary 
mechanical barrier between transplant and bone marrow during 
implantation concurring to reduce immunogenicity of chondro-
cytes (29). It has been reported that differentiated DC pulsed with 
supernatant from allogeneic hAC can efficiently trigger immune 
response and that TNF-α further increased this effect (30, 31). 
This suggests that already differentiated DC are insensitive to 
hAC-mediated regulation and that the immune response to 
allogeneic chondrocytes implantation can be different in relation 
to the presence of fully mature APC in the microenvironment.
The conditioned media (CM) from Mo–hAC co-cultures can 
affect the differentiation of Mo to iDC and mDC demonstrating 
that soluble factors can be involved. Among the different factors 
that could possibly play a role in immune-regulation and impair-
ment of Mo to DC differentiation (24, 32, 33), PGE2 has been 
identified to impair Mo to DC generation. Most importantly, the 
presence of PGE2 in CM of Mo with hAC cultures suggests that 
PGE2 could be a suitable candidate as responsible factor for the 
impairment of Mo differentiation to DC. In this context, two rel-
evant types of immunoregulatory cells have been reported to be 
sensitive to PGE2 increase, such as regulatory T cells (Tregs) and 
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FigUre 7 | human ac do not stimulate allo-response and inhibit Mlr as a third party. (a) Allogeneic hAC were used as stimulator of PBMC of three 
donors labeled with CFSE at the PBMC:hAC ratio of 10:1. Proliferation was evaluated at day 7 and it was assessed as decrement of CFSE content in CD3+ T cells 
(identified by indirect immunofluorescence with anti-CD3 mAb UCHT-1 followed by goat APC-conjugated anti-mouse isotype specific antiserum). Results are 
expressed as % of CD3+ T cells with decrement of CFSE content compared to PBMC cultured alone. MLR between the three different PBMC donors was shown for 
comparison to define whether PBMC can indeed proliferate upon allo-recognition. (B) Regulation of MLR with hAC as a third party. MLR were set up in the presence 
of hAC (as a third party) at the responder PBMC:hAC ratio of 10:1 and proliferation evaluated as in (a) as decrement of CFSE content in CD3+ responder T cells. 
Ctr: level of proliferation of CD3+ T cell in the MLR. Results are expressed as % of CD3+ T cells with decrement of CFSE content. Responder PBMC cultured alone 
showed a proliferation of 3–7%.
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myeloid-derived suppressor cells (MDSC) (34–36). Thus, PGE2 
can amplify the regulatory activity of Treg and MDSC (34–36). 
It is still to be defined whether in co-culture with hAC can be 
generated either Treg or MDSC. In this context, it is evident that 
intact cartilage can release several factors, such as TGF-β, that can 
influence the microenvironment (37) and lead to the generation 
of Tregs (37, 38).
Most importantly, chondrocytes can be derived from bone 
marrow MSC under appropriate culture conditions (39), 
and it has been reported that MSC-derived chondrocytes 
increases antidonor immune response (10). In this context, it 
is conceivable that some chondrocytes of articular cartilage 
may be derived from MSC migrated from the bone marrow. 
Interestingly, it has been reported (40) that MSC from bone 
marrow can down regulate DC maturation from peripheral Mo 
at a Mo:MSC ratio of 5:1 that is about 100-fold lower than that 
showed by hAC in our hands. This different efficiency between 
MSC and chondrocytes in regulating Mo differentiation can be 
related to the origin of the two different cell populations. Indeed, 
MSC were from bone marrow of young children and in that 
site they played a key role in the regulation of differentiation 
of hematopoietic cell precursors (41). In our experiments, 
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chondrocytes are from articular cartilage of old patients and 
they are committed to produce factors typical of differentiated 
chondrocytes (Figure  1). In addition, it has been reported 
that MSC can regulate Mo differentiation through PGE2 and 
indoleamine dioxigenase (IDO) activity (40) while in our 
hands, kynurenine, a metabolite of IDO activity on tryptophan 
aminoacid, did not affect consistently Mo differentiation. This 
would suggest that some of the different experimental settings, 
used in our vs. previously reported experiments, could be the 
reason of the different inhibitory degree of chondrocytes. By 
the use of rat subcutaneous implantation model, it has been 
shown that rat chondrogenically differentiated MSC acquire 
a more immunogenic phenotype (10). In this experimental 
system, MSC differentiated into chondrocytes expressed high 
levels of co-stimulatory molecules as CD80 and CD86 (10). It 
is well known that CD80 and CD86 are accessory molecules 
essential for giving to T cell the second signal to trigger prolif-
eration through the engagement of CD28 at the T cell surface 
(9). Although not shown, chondrocytes used in our experiments 
did not express CD80 and CD86 neither at the protein nor at the 
mRNA level. Thus, this difference is an additional putative rea-
son, besides the origin and species, of the different behavior of 
chondrogenically differentiated MSC and our hAC. The premise 
of isolated chondrocytes immune privilege remains contested, 
as studies using different species and different experimental 
designs have supported or refused this theory. In this context, 
Adkisson et al. reported that juvenile chondrocytes presented a 
stronger immune modulatory effect than adult chondrocytes. 
Young chondrocytes not only failed to active T cells but also 
were able to inhibit activated T cells proliferation possibly by a 
mechanism involving the co-stimulatory molecule B7-1–CD80 
(42). More recently, Lohan et  al. reported that rat articular 
chondrocytes did not induce T cell activation and were able 
to modulate ongoing T cell proliferative response through the 
release of nitric oxide (43). Also, in the reported culture system, 
rat chondrocytes presented immunosuppression properties, 
fact that is in line with our outcomes using different approaches 
and different cell spices. Additionally, it was demonstrated that 
low doses of PGE2 revealed beneficial effects on the phenotypic 
differentiation of hAC in different culture system (44).
Despite these observations, we have to take into con-
sideration that classic ACI requires the use of autologous 
chondrocytes isolated from biopsy samples. Cells expanded 
in monolayer inevitably undergo into dedifferentiation process, 
which compromise phenotypically traits. The quality of the 
delivered allogenic chondrocytes combined to robust effect of 
hAC on the proliferation and functionality of T and professional 
APC could play a crucial role in the inflammatory response 
during tissue repair process. Accordingly, allogeneic hAC do 
not trigger allo-immune response and they impair MLR as a 
third party in in vitro experiments, which indicates that hAC 
regulation of immune response can overcome allostimulation. 
Nevertheless, it would be useful to investigate in an appropri-
ate animal model if chondrocytes, whether inside their dense 
matrix or navigating in the synovial fluid, maintain the observed 
immune behavior and the capacity to repair the original hyaline 
cartilage tissue.
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FigUre s1 | hac inhibit T lymphocyte proliferation. (a) PBMC were 
isolated from peripheral blood, labeled with CFSE and co-cultured with hAC at 
the PBMC:hAC ratio of 5:1. PBMC were stimulated with anti-CD3 mAb (20 ng/
ml) or PHA (5 μg/ml) or SEB (10 ng/ml) for 4 days and T cell proliferation was 
assessed as decrement of CFSE content in CD3+ T cells (identified by indirect 
immunofluorescence with anti-CD3 mAb UCHT-1 followed by goat APC-
conjugated anti-mouse isotype specific antiserum). Results were shown as log 
green fluorescence intensity arbitrary units (a.u.) of CFSE content vs. log far red 
fluorescence intensity. One representative experiment out of 10 performed. 
Medium indicates the CFSE content and CD3 expression in unstimulated 
PBMC. Upper row proliferation of PBMC alone; lower row proliferation of 
PBMC co-cultured with hAC. (B) CFSE content gated on CD3+ T cells 
[corresponding to the cells depicted in upper left and upper right quadrant of 
(a)] on PBMC (upper subpanels) or PBMC co-cultured with hAC (lower 
subpanels) of unstimulated PBMC (medium) or PHA stimulated PBMC (right 
subpanels).
FigUre s2 | hac inhibit directly cD4+ T cell proliferation triggered 
through cD3 and cD28. (a) Highly purified peripheral blood CD4+ T cells 
labeled with CFSE were co-cultured with hAC at the CD4+ T cell:hAC ratio of 5:1 
in the presence of anti-CD3 and anti-CD28 coated beads and proliferation was 
assessed on day 3 by FACS analysis of CFSE decrement compared to 
unstimulated CD4+ T lymphocytes (medium). Lower subpanels show the 
proliferation on day 3 of CD4+ T cells in the presence of exogenous IL-2 added at 
day 2 of stimulation assay. Results are representative of 10 different experiments 
using 6 different preparations of hAC and 10 donors of CD4+ T cells. (B) Images 
of cell cultures of (a).
FigUre s3 | Features of peripheral Mo cultured with hac. Mo were 
isolated from PBMC as CD14+ cells by Easy-Sep do-it yourself kit and analyzed 
for the expression of CD14 and CD16 to identify different Mo subsets by 
indirect immunofluorescence and FACS analysis (45). (a) left. Physical 
parameters as forward scatter (FSC, x-axis) and side scatter (SSC, y-axis) of 
total peripheral blood mononuclear cells (PBMC), three different populations 
can be identified: low FSC–low SSC: debris-platelets; high FSC–low SSC: 
lymphocytes; and high FSC–high SSC Mo (circled by gate). (a), right. FSC and 
SSC of CD14+ purified Mo; (B) Double immunofluorescence of purified CD14+ 
cells from PBMC with anti-CD14 mAb (x-axis) and anti-CD16 mAb (y-axis) 
followed by anti-isotype-specific PE and Alexafluor 647 goat anti-mouse 
antiserum. (c) FSC and SSC of Mo cultured for 6 days with GM-CSF (20 ng/ml) 
and IL-4 (20 ng/ml) without (upper dot plot) or with hAC (lower dot plot). Circled 
dots were those analyzed for the expression of the different differentiation 
markers shown in Figure 4. Lymphocytes represented less than 5% of total cell 
population used for the analysis. (D) Morphological features of Mo cultured for 
6 days without (left) or with hAC (right) in medium (upper images) or with 
GM-CSF + IL-4 (lower images). Images were taken with IX70 Olympus inverted 
microscope at 100× magnification equipped with an ORCA Hamamatsu 
camera. Bar: 10 μm.
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FigUre s4 | effect of hac on peripheral blood Mo to dendritic cell 
differentiation. Immunofluorescence analysis of Mo isolated from peripheral 
blood (PB monocytes) (first upper row), or cultured with GM-CSF (20 ng/ml) and 
IL-4 (20 ng/ml) (second row) or with GM-CSF + IL-4 and hAC (third row) or with 
GM-CSF + IL-4 + LPS (1 μg/ml) (fourth row) or with GM-CSF + IL-4 + LPS and 
hAC (fifth row). GM-CSF and IL-4 (6 days of culture) were used to induce 
differentiation of PB Mo to iDC (second and third rows), while the addition of LPS 
(6 days of culture + additional 2 days with LPS) was used to further induce 
differentiation of iDC to mDC (fourth and fifth rows). Cells were harvested from cell 
culture wells and labeled with anti-CD1a-FITC, anti-CD14-PE-Cy7, anti-CD80-
Violet, anti-CD83-APC, and anti-CD86-PE-conjugated antibodies. Five-color 
immunofluorescence analysis was performed with the CyAN ADP cytofluorimeter 
and at least 10,000 events for each dot plot have been analyzed. Analysis was 
performed on gated Mo as indicated in Figure S2 in Supplementary Material. 
Each subpanel was divided into four quadrants (upper left, single-positive cells for 
the indicated markers on y-axis; upper right double-positive cells co-expressing 
CD1a; lower left double-negative cells; lower right single CD1a+ cells) on the 
basis of negative controls stained with an unrelated mAb matched for the isotype. 
Optimal compensation between the various color was performed using 
auto-comp included in Summit analysis program and confirmed by the staining of 
cells with one or another single antibody. Results are expressed as mean Log 
green fluorescence intensity of CD1a and the mean of fluorescence intensity of 
each marker indicated on y-axis in arbitrary units (a.u.). Results are 1 out of 15 
independent experiments using different hAC preparations and 8 Mo donors.
FigUre s5 | effect of conditioned media from Mo–hac co-cultures on Mo 
differentiation to iDc. Mo or hAC or Mo and hAC were cultured with GM-CSF 
and IL-4 for 4 days. Then, conditioned media were harvested and added (1 in 2 
diluted) to Mo induced to differentiate to iDC with GM-CSF and IL-4. On day 3 
(upper dot plots) and day 6 (lower dot plots), cells were harvested and stained with 
anti-CD1a-FITC and anti-CD14PE-Cy7 mAbs. Samples were run on a CyAN ADP 
cytofluorimeter and results are representative of three independent experiments.
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